Trial of pIL-12 Electroporation Malignant Melanoma

NCT01502293 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

51

Enrollment

INDUSTRY

Sponsor class

Conditions

Melanoma

Interventions

BIOLOGICAL: Tavokinogene Telseplasmid (tavo)
DEVICE: OncoSec Medical System (OMS)

Sponsor

OncoSec Medical Incorporated